InvestorsHub Logo
Followers 239
Posts 12068
Boards Moderated 0
Alias Born 08/14/2003

Re: BIOChecker4 post# 454827

Saturday, 03/23/2024 5:22:41 PM

Saturday, March 23, 2024 5:22:41 PM

Post# of 458500
You may be very right that someone else would have done better, however if in time he gets the job done, he'll still be credited with the success of the company. He had been at IMGN before, and probably reacts like nearly all IMGN's CEO's have acted. I was there for decades not because I liked the management, I didn't, but because I believed in the technology. I opposed the buyout, but clearly management had the Institutions behind them and sold out at the first opportunity to do so and make a nice gain. I profited nicely, but still believe it should have been worth substantially more if they waited longer to establish a revenue stream for Elahere.

My point is that in most successful biotech's there are times when management is put down terribly, but if approvals are gained they're toasted as heros. NWBO is my biggest holding, it's heavily bashed and is going after the MM's for spoofing. Many put down the CEO, but frankly I believe that many others would have thrown in the towel long ago, so I very much support her. I believe we'll see UK approval in the next two months, the other regulators including the FDA by next year at the latest. It's worth looking at, it's vaccine which is personally made from the patients tumor will be shown to be tumor agnostic in time, if it's not acquired no telling how far it can go.

Gary
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News